Burkhart Erin

Burkhart Erin is listed in filings as SVP at Gilead Sciences (2020 Irrev Trust FBO Grandchildren). This profile follows SEC Form 4 activity through Mar 12, 2026, including sale activity. Recent filings connect the profile to Gilead Sciences (2020 Irrev Trust FBO Grandchildren) (GILD) and Biomarin Pharmaceutical Inc (BMRN). The current snapshot covers public activity from Aug 15, 2024 to Mar 12, 2026. Reported amounts are shown as $810.4K to $91.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.